Intended Use
HG Rapid Test FIV is a chromatographic immunoassay kit for rapid and qualitative detection ofthe antibodies"against feline immunodeficiency virus (FIV) in feline blood. The nitrocellulose membrane of the kit is immobilized with FlV-specific antigen in testline and with anti-mouse antibodies in the control line.And also,FIV-specific antigen is conjugated to the colloidal gold particles.This conjugate is placed on a polyester or glass fiber as conjugate pad.When the sample is dropped into the sample well on the device, the solubilized conjugate migrates with the sample by passive diffusion and both the conjugate and sample come into contact with the antibody that immobilized onto the nitrocellulose. If the sample contains FIV antibodies, the result is visible as red line within ~10minutes in the test line on the membrane.The solution continues to migrate to encounter a control reagent that binds a control conjugate,thereby producing another red control line.
Symptons
Weight loss,
Seizures,
Behavioral changes and neurological disorders
Features
1 This product uses the principle of colloidal gold immunochromatography to quickly detect FIV antibody.
2 This product does not require special instruments, and can be quickly and easily implemented on-site inspection.
3 Using high-purity raw materials and high-quality materials, it shows extremely high sensitivity and specificity.
Operation
Place all specimens, test devices, and Assay solution and allow them to room temperature prior to testing (15~30 min).
Prepare the test device as you need, and then mark the patients,ID onto the device, Please perform the test immediately after removing the device from foil pouch..
Load 1 drop (10 μL) of specimen into the sample well (S)
Add 3 drops of Assay Solution into the sample well(S).
Interpret the testing result within 10 minutes.Do not read the result after 10 minutes.
Interpretation of Results
This product is aimed to facilitate public health institute worldwide to increase their diagnostic capabilities when facing the emerging Feline immunodeficiency virus health challenge, allowing for an efficient and rapid public health response in the case of an outbreak.